Asset-Backed Specialty Finance Facility

The Client

Kevin White is Managing Director of a specialty finance platform that originates and warehouses receivables across several asset classes. The platform had a strong origination engine and a clean servicing track record, but its growth was constrained by the cost and availability of warehouse capital. Kevin approached Edge with a specific problem: the platform needed a materially larger, cheaper facility to keep pace with origination volume, and the conventional lenders it had approached were either declining or pricing the facility at levels that made the underlying business uneconomic.

"Edge structured a specialty finance facility that conventional lenders wouldn't touch. They understood the collateral, priced the risk correctly, and brought the right capital partners to the table."
— Kevin White, Managing Director, Specialty Finance

The Problem

The receivables portfolio was granular and diversified — thousands of small-balance obligations across multiple originating channels. That diversification is a genuine credit strength: no single obligor represents meaningful concentration, and the law of large numbers makes portfolio-level loss rates highly predictable. But it created three specific obstacles for conventional warehouse lenders:

• Collateral illegibility. Bank credit committees are built to underwrite a handful of large, rated counterparties — not a statistical distribution of thousands of small ones. The portfolio didn't fit the box, so it was routed to exception underwriting, where it stalled.
• First-loss anxiety. Lenders were willing to fund a senior advance rate but wanted a first-loss cushion far larger than the portfolio's actual historical loss experience justified. That gap — between modeled loss and demanded cushion — is what made the facility uneconomic for the sponsor.
• Timeline mismatch. The sponsor had origination commitments that required funding within the quarter. The conventional bank process, with its exception-underwriting detour, would not have closed in time.

In other words, the deal wasn't uncreditworthy. It was mispriced by the market because the parties best positioned to fund it couldn't read the collateral, and the cushion they demanded to compensate for that illegibility priced the sponsor out.

The Edge Structure

Edge's thesis was straightforward: if the barrier is the first-loss cushion, transfer the first-loss risk to a party equipped to price it, and the senior capital becomes both available and cheap. The structure had three components.

1. Risk-transfer wrap over the first-loss layer

Edge worked with a specialty carrier to structure a credit risk-transfer wrap covering losses in the portfolio above the sponsor's retained equity and below the senior attachment point. The carrier — unlike a bank credit committee — underwrites statistical loss distributions for a living. Given the portfolio's documented loss history and diversification, the carrier could price the first-loss layer at a rate that reflected actual expected loss rather than the conservative cushion a bank would demand. The wrap converted an illegible risk into a rated, insured obligation.

2. Rated senior tranche

With the first-loss layer wrapped by A-rated paper, the senior tranche's risk profile changed materially. Edge structured the capital stack so the senior tranche could be presented to a rating agency with the wrap embedded. The tranche secured an A− rating — which, in turn, opened it to the deep pool of institutional investors whose mandates require investment-grade paper.

3. Institutional private credit placement

Rather than route the senior tranche back through the bank market that had already balked, Edge placed it with an institutional private credit fund pre-positioned for rated, asset-backed specialty finance exposure. The fund could fund the full senior advance quickly, at a spread reflecting the now investment-grade risk profile, and on the sponsor's timeline.

The Outcome

The facility closed at $140M, 11 weeks from signed engagement to funding — inside the sponsor's origination commitment window. The all-in cost of capital, blending the wrap premium and the senior spread, came in meaningfully below the level the conventional lenders had quoted for a smaller, more restrictive facility. Because the senior tranche was rated and placed with a committed institutional partner, the facility also carried a clearer path to upsizing as origination volume grows — the structure is repeatable, not bespoke to a single funding round.

For Kevin's platform, the practical result was capital that matched the economics of the underlying business: a larger facility, at a lower cost, closed on the timeline the origination pipeline demanded.

What This Illustrates

This transaction is a clean example of the Edge thesis across specialty finance: the barrier to funding is often not credit quality but legibility — the mismatch between how a portfolio actually behaves and how the conventional capital market is equipped to read it. Where that mismatch exists, specialty insurance is frequently the tool that closes it: transferring the illegible layer to a party equipped to price it converts a stalled deal into ordinary, fundable, investment-grade risk.

The same structuring logic applies well beyond receivables — to litigation finance, royalty streams, equipment portfolios, and other granular asset classes where the collateral is sound but doesn't fit the conventional lender's underwriting model.

Transaction details have been generalized to protect commercial confidentiality. Figures and structure are representative of the engagement. This case study is for informational purposes and does not constitute an offer of securities, insurance, or financial advice.